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ABSTRACT
This study investigated (1) the ability of an organotypic model of spinal cord injury (SCI)
to recapitulate significant pathobiological events of in vivo SCI from a Raman
spectroscopic perspective, and (2) the Raman spectroscopic effects of chondroitinase
ABC (cABC) treatment on said model of SCI. Tissue from mouse spinal cords was
excised, sectioned, and placed into culture, before being systematically injured to
induce trauma. Cultures with and without cABC treatment were assessed using Raman
spectroscopy at varying times post-injury. We demonstrate that Raman spectral
phenomena characteristic of SCI can be observed using an organotypic model. By
comparing these phenomena with well-known cellular mechanisms of SCI, we
hypothesize their correlation with apoptosis, demyelination, and upregulation of
endogenous biochemicals, such as chondroitin sulfate proteoglycans (CSPGs), among
others. Furthermore, we demonstrate for the first time that Raman spectral phenomena
are discernable during cABC treatment of SCI. Observed spectral variations correlate to
the enzymatic degradation of CSPGs, protein compositional changes, and remyelination.
Multivariate regression modeling confirms changes in lipid and chondroitin sulfate
concentration during SCI and its cABC treatment, and provides a semi-quantitative
measure of these changes. Overall, these data establish Raman spectroscopy as a
viable resource for monitoring cABC treatment of SCI.
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SPECIFIC AIMS
1. Using Raman spectroscopy, assess the ability of an organotypic model of spinal
cord injury (SCI) to recapitulate significant pathobiological events of in vivo SCI
2. Using Raman spectroscopy, assess the effects of chondroitinase ABC (cABC)
treatment on organotypic SCI, and whether those effects, if any, correlate to the
reported enzymatic action of cABC on spinal tissue
3. Construct a multivariate regression model of organotypic SCI and its treatment
with cABC, using the acquired Raman spectra, to quantify changes in
biochemical composition
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INTRODUCTION

When the spinal cord is injured, it responds by producing an axonal inhibitory matrix
referred to as the glial scar.1-3 This response prevents severed axons from forming new
connections across the injury site, an event that, if done incorrectly, could be
devastating to functionality in the central nervous system (CNS).1-3 Rather than risk a
potentially detrimental reconnection, the injured spinal cord uses the scar to impede
axonal regrowth and preserve its residual physical and chemical integrity. However, this
preventative measure comes at a price, as many victims of spinal cord injury (SCI)
consequently suffer partial or complete paralysis from failed axonal regeneration. SCI
victims in the United States alone number approximately 270,000, and of those more
than 99% are paralytic.4 To combat SCI and its debilitating effects, numerous efforts
have been made to understand the underlying mechanisms of the glial scar.5-8 It is, at
least in part, a function of two key events. First, axons extending into the site of injury
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are demyelinated by the apoptosis of oligodendrocytes, the myelinating cells of the CNS.
The apoptotic fragmentation of the oligodendrocyte membrane releases myelinassociated growth inhibitors, which, when bound to complementary receptors, prohibit
axonal growth. Additionally, demyelination prevents the proper electrical conductivity
necessary for neurons to signal, making communication across the injury site highly
improbable.8,9 Second, reactive glial cells concurrently, and vigorously, upregulate
chondroitin sulfate proteoglycans (CSPGs), which are secreted to produce a CSPG-rich
extracellular matrix. The chondroitin sulfate glycosaminoglycan (CS-GAG) side-chains
of CSPGs then bind to complementary receptors on axons, triggering a signaling
pathway to further prohibit axonal growth.9,10 Thus, CSPGs act as a physical barrier, by
means of sheer concentration, and chemical barrier to axon regeneration.
It is reported that CSPGs are among the most proactive of axonal inhibitory
molecules.10 For this reason, numerous studies have focused on anti-CSPG SCI
therapies using the bacterial enzyme chondroitinase ABC (cABC).1, 11-14 This enzyme
catalyzes the removal of CS-GAG chains from CSPG, which in turn attenuates CSPG’s
inhibitory action, both as a physical and chemical barrier. However, despite the success
of anti-CSPG therapies, assessment thus far has relied on immunohistochemical
techniques, which require preparation of tissue and further, possibly unwanted,
alteration of the tissue’s chemical state (e.g. fixation and staining). In recent years,
Raman spectroscopy (RS) has emerged as an effective alternative in examining tissue
chemistry, one that is operable in living tissue without any necessary chemical
treatments.15 Without the requirement of tissue preparation, RS has appreciable
potential as a clinical tool for real-time assessment of SCI treatment. Ideally, the
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spectroscopic technique would be used to non-invasively monitor the chemistry of
treated SCI, facilitating necessary tailoring of the treatment. This study serves as a
preliminary, in vitro exploratory effort to the aforementioned clinical therapy. The
effectiveness of RS has already been demonstrated in the assessment of SCI.16,17
However, no reports to date have used RS to examine the effects of anti-CSPG
treatments. To that end, we present a novel Raman spectroscopic investigation, in
qualitative and semi-quantitative nature, of SCI and its treatment with chondroitinase
ABC in an organotypic model.
Firstly, we demonstrate a functional model of SCI - on which our spectroscopic
investigation was based - using an organotypic culture platform. The animal chosen for
this model was the mouse. Organotypic cultures are tissue explants, typically in the
form of thin slices, which have been placed directly into culture without modification.
This style of preparation preserves the original histological and morphological structures
of the tissue, allowing regional specific observations. Once in culture, organotypic slices
largely maintain the ability to recapitulate in vivo pathobiology, despite lacking extrinsic
inputs.18 This has been extensively demonstrated for tissue of the CNS.19-22 The
organotypic culture platform was chosen, foremost, because it allows SCI to be
performed entirely in vitro, facilitating a repeatability of injury that is amply more difficult
to achieve in vivo.18 In this study, tissue was excised from the spinal cords of mice,
sectioned into uniform slices, placed into culture, and systematically injured using a
weight-drop device. In this way, the mechanics of injury were precisely controlled so
that the injury mode and injury severity remained uniform between groups of tissue.
Whereas the mechanics of in vivo injury can be controlled, it can only be done so
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externally, meaning internal tissue injury cannot be regulated with the same degree of
precision as in vitro injury.18 For our purposes uniformity of injury was necessary, as our
assessment did not pertain to the level of injury severity. Moreover, in vitro injury is
ethically advantageous to in vivo injury, as it does not necessitate post-surgical animal
care. As an additional motive, organotypic cultures offer precise control over the
environmental conditions of excised tissue, which allows highly repeatable treatment.
Direct administration of cABC into the culture medium lessened the possibility of a nonuniform drug distribution, to which a vascularized in vivo environment might be
conducive, thus further removing variation between groups. Secondary motives include
the cost effectiveness of the platform, since there is no post-surgical care, and ease-ofuse, since surgery was not required immediately prior to analysis, as is necessary in in
vivo studies to prevent tissue decay.16
With the SCI model in place, cultures with and without cABC treatment were
assessed using Raman spectroscopy at varying times post-injury. We investigated (1)
the ability of an organotypic model of SCI to recapitulate significant pathobiological
events of in vivo SCI from a spectroscopic perspective and (2) the Raman
spectroscopic effects of cABC on our model of SCI, and whether those effects
correlated to the reported enzymatic action of cABC on spinal tissue. These
characterizations are qualitative in nature. To quantitatively supplement our
spectroscopic findings, partial least squares (PLS) regression was employed to
construct a multivariate model of tissue composition during SCI and its treatment. The
goal of the PLS regression was to ascertain the relative contribution of predetermined
reference biochemicals, intrinsic to spinal tissue, to the chemical compositional profile of
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organotypic spinal tissue cultures. This was executed by finding the commonality
between the spectra of the reference biochemicals and the spectra of the tissue.
3

MATERIALS AND METHODS

3.1 Preparation of organotypic spinal cord slice cultures
The animal protocol was approved by the Institutional Animal Care and Use Committee
(IACUC) at Syracuse University and was in compliance with the National Institutes of
Health (NIH) guidelines. All following procedures were performed in a sterile laminar
flow cabinet. Adult female mice (Mus musculus) were anesthetized with isoflurane and
decapitated using a rodent and small animal guillotine. The animal was positioned
ventral side up and pinned into place on an ice-cold dissection board. The skin and
musculature were removed from the ventral side along the midline. The ventral half of
the ribcage was removed, and all organs were cleared from the thoracic cavity to
expose the vertebral column. Once exposed, the vertebral column was constantly
superfused with sterile, ice-cold artificial cerebral spinal fluid (ACSF) [124 mM NaCl, 3
mM KCl, 1.25 mM KH2PO4, 4 mM MgSO4, 2 mM CaCl2, 26 mM NaHCO3, 10 mM Dglucose, 2 mM ascorbic acid, and 75 µM adenosine (Sigma, St. Louis, MO); pH 7.2] to
slow the inflammatory response. To access the spinal cord, an incision was made
through the pedicle on either side of the first thoracic vertebra (T1) and extended down
the length of the thoracic spine, separating the vertebral bodies from the lamina. The
vertebral bodies were then lifted from the cord. Using microscopic assistance, the dorsal
and ventral roots were transected.
Next, the thoracic region of cord (T1-T13) was excised and placed into a petri
dish containing sterile, ice-cold ACSF. The thoracic region was chosen for its uniform
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cross-sectional area. The time between decapitation and submersion of the spinal cord
in ACSF was minimized to within 10 minutes to ensure minimal inflammation. The cord
was transferred to a separate petri dish containing 30°C low gelling temperature
agarose (4% w/v in ASCF), which was immediately placed on ice to induce gelation.
Once gelled, an agarose block containing the cord was cut from the bulk using a scalpel
and fixed onto a metal disk with cyanoacrylate. The embedded cord was cut into 400µm-thick transverse slices [Fig. 1(a)] using a tissue chopper (McIlwain, ON, Canada)
equipped with a Feather double-edge carbon steel blade (Ted Pella, Redding, CA). The
slices were immediately transferred into sterile, ice-cold ACSF, where they were gently
stripped of meninges and checked for structural quality. Any incomplete or damaged
slices were discarded.
Finally, slices were transferred onto Millicell culture plate inserts (PTFE
membrane, 0.4 µm pore size; EMD Millipore, Billerica, MA) using a sterile wide-end
pipette. The slices were plated three per insert, and arranged without contact between
one another. The culture inserts were placed into a 6-well plate, with each well
containing 1.0 mL of culture medium. Culture medium consisted of 50% minimum
essential medium (MEM) with L-glutamine (Invitrogen, Carlsbad, CA), 25% normal
horse serum (Invitrogen), 25% Hank’s balanced salt solution (HBSS) (Invitrogen), 20
mM HEPES (Invitrogen), 6.5 g/L D-glucose (Sigma), 50 µg/mL penicillin (Invitrogen), 50
U/ml streptomycin (Invitrogen) and was adjusted to a pH of 7.3. In this method of
culturing, adapted from Stoppini et al23, tissue slices have two distinct interfaces from
which they receive necessary resources, an air-to-tissue interface and a medium-totissue interface. Slices were allowed to passively warm to room temperature before
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being placed in incubation at 37°C and 5% CO2. The cultures were incubated for a
maximum of 14 days in vitro (DIV), and the medium was changed every 3 days.
3.2 In vitro SCI
Slices were cultured for 6 DIV before inducing SCI to allow acclimation to the culture
conditions. SCI was induced using a weight drop apparatus housed in a sterile laminar
flow cabinet. This technique was adapted from Krassioukov et al.24 A headed stainless
steel pin with a 2.0 mm diameter head and 0.5 g total weight was dropped from a height
of 5.0 mm onto the center of the slice [Fig. 1(a)]. The cross-sectional area of the head
was sufficient to cover the entire slice surface. Immediately following injury, slices were
placed back into incubation at 37°C and 5% CO2. Control slices were removed from
incubation for an equivalent time period and placed back into incubation without injury.
Injured (SCI) groups and uninjured control (CTL) groups were analyzed at 1, 4, and 8
day(s) post-injury (DPI) [Fig. 1(b)].
3.3 Measurement of cell death
Cell death was assessed using the nucleic acid stain, propidium iodide (PI) (Invitrogen,
Carlsbad, CA). PI is only permeable through the damaged membranes of non-viable
cells. Upon cellular entry, PI binds to nucleic acids, causing a significant increase in its
fluorescence emission maximum and a forward shift in its excitation and emission peaks.
PI was dissolved in serum free medium [75% MEM with L-glutamine (Invitrogen), 25%
HBSS (Invitrogen), 20 mM HEPES (Invitrogen), 6.5 g/L D-glucose (Sigma, St. Louis,
MO), 50 µg/mL penicillin (Invitrogen), 50 U/ml streptomycin (Invitrogen); pH 7.3] at 5
µg/ml. Serum free medium was used to reduce the fluorescence noise generated by
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Fig. 1 (a) Overview of organotypic culture preparation and injury. Left image shows the transverse cutting plane used
to section the spinal cord; middle, the slice-interface culture method adopted from Stoppini et al.; right, the weightdrop apparatus used for injury. (b) Timeframe of experimental procedure. Cultures were allowed a period of 6 DIV
th
before injury to ensure healing from the harvesting procedure, with injury occurring on the 6 day. One hour postinjury, cultures were treated, or not, with cABC. Spectroscopic and histological analysis was performed at 7, 10, and
14 DIV, which correspond to 1, 4, and 8 DPI.

	
  
esterase activity found in normal horse serum. Slices were removed from their current
medium, gently rinsed in 1X phosphate buffered saline (PBS) to remove residual serum,
and introduced to 1.0 mL PI solution.
Slices were then placed back into incubation at 37°C and 5% CO2 for 1 hour to allow for
permeation of PI. Fluorescence intensity was measured using a LSM 710 Confocal
Microscope (Zeiss, Germany) controlled by ZEN 2010 B SPI1 software (Zeiss). PI was
excited with a 543 nm Helium-Neon laser, and emissions were collected with a 605–670
nm band pass filter. A z-stack of 5 images separated by 10 µm intervals was collected
in 3 non-overlapping locations for each slice using a 10X objective. The field of view,
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gain, and pinhole size were standardized for all images. The mean emission intensity, a
built-in function of the ZEN software, was collected for each image. Slices were then
killed by submersion in 4°C PI (0.5 mg/ml solution in 1X PBS) for 72 hours. Using an
identical procedure, dead slices were re-imaged to obtain a mean emission intensity
that represented 100% cell death. The percent cell death for each slice was expressed
as its ‘alive’ mean emission intensity normalized by its ‘dead’ mean emission intensity.
To assess cell death over the duration of the culture period, groups of cultured slices
(n=3) were analyzed at 1, 3, 7, 10, and 14 DIV. To assess cell death in response to SCI,
SCI groups (n=3) and CTL groups (n=3) were analyzed at 1, 4, and 8 DPI. The variable
‘n’ refers to the number of slices.
3.4 Chondroitinase ABC treatment
Lyophilized chondroitinase ABC (cABC) (Seikagaku Corporation, Tokyo, Japan) was
reconstituted in a 0.01% aqueous bovine serum albumin solution (Invitrogen, Carlsbad,
CA). A buffer solution consisting of 10 U/ml reconstituted cABC, 50 mM Tris (Invitrogen),
60 mM sodium acetate (Sigma, St. Louis, MO), and 0.02% bovine serum albumin was
added to culture medium for a final cABC concentration of 0.2 U/ml. This solution is
referred to as cABC medium. Injured slices were cleared of culture medium and
administered 1.0 ml of cABC medium 1-hour post-SCI. The cABC medium was
refreshed every three days following initial treatment. Note that the in vitro half-life of
cABC is approximately 8 days.12 As a sham-control, separate groups of injured slices
were administered culture medium supplemented with 2.0% 1X PBS. Groups treated
with cABC (SCI +cABC) and sham-control groups treated with PBS (SCI +Sham) were
analyzed at 4 and 8 DPI.
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3.5 Raman spectroscopy of organotypic cultures
Raman spectroscopy was performed using a custom built Raman spectroscope
(Fig. 2).25 For all procedures, an external cavity 785 nm laser diode (Process
Instruments, Salt Lake City, Utah), adjusted to a measured power of 500 mW and spot
size of 300 µm, was used as an excitation source. Excitation light was redirected 90°
from the horizontal by a periscope and passed through a pinhole located in the center of
a downward facing plane mirror. Excitation light then contacted the transverse plane of
the tissue slice at normal incidence, and backscatter emissions were redirected back to
the horizontal direction by the plane mirror. Emissions were passed through a pair of
convex lenses and into a SuperNotch laser line rejection filter (Kaiser Optical Systems,
Ann Arbor, MI) before entering a HoloSpec f/1.4 spectrograph (Kaiser) equipped with a
100 µm entrance slit. The spectrograph had a low-frequency stokes grating that
operated over the spectral range -34 to 1894 cm-1 and was coupled with a nitrogencooled iDus 420 series CCD Detector (Andor, Belfast, UK) to produce a spectral
resolution of 2.0 cm-1.
Slices were cleared of culture medium and washed gently with PBS prior to
imaging. Culture plate inserts containing the slices were removed from their 6-well
plates and placed on an adjustable stage. Slices were positioned over an optical trap to
reduce unwanted emissions. The laser focal spot was then positioned within the white
matter of the spinal cord. Each spectrum was collected as 300 accumulations of 1.0second integrations (total time of 5 minutes), and a minimum of 3 spectra was collected
per slice, with each spectrum taken from a unique location within the white matter.
Between acquisitions, slices were superfused with room temperature PBS to maintain
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hydration. Spectra of the PTFE membrane underlying the slices were collected under
identical parameters. During spectroscopic analysis, PTFE spectra were subtracted
from tissue spectra to remove the Raman spectral features contributed by the PTFE
membrane (See Section 3.7). All experiments were done at room temperature. Slices
were discarded following analysis. To assess how the culturing of spinal cord tissue
affects its Raman spectral features, a group of uncultured slices (n=3) was analyzed
immediately following slicing, and groups of cultured slices (n=3) were analyzed at 6,
10, and 14 DIV. Uncultured slices underwent an identical preparation procedure to
cultured slices, but were not placed in incubation and instead analyzed immediately
following slicing. To asses the progression of SCI and its treatment with cABC, SCI
groups (n=6) and CTL groups (n=3) were analyzed at 1, 4, and 8 DPI; and SCI +cABC
groups (n=6) and SCI +Sham groups (n=3) were analyzed at 4 and 8 DPI. The variable
‘n’ refers to the number of slices.
3.6 Raman spectroscopy of biochemical constituents
See Section 3.5 for a description of the Raman spectroscope used to perform the
following experiments. Triolein (≥99%), actin (from bovine muscle), cholesterol (≥99%),
collagen type IV (from calf skin), collagen type I (from calf skin), chondroitin-6-sulfate
(CS-C), chondroitin-4,6-sulfate (CS-E), glial fibrillary acidic protein (GFAP), myelin basic
protein (≥90; bovine), histone (type IIA from calf thymus), and deoxyribonucleic acid
(DNA) (from human placenta) (Sigma, St. Louis, MO) were chosen as representative
biochemical constituents of spinal tissue, to be used for regression analysis. These
chemicals were selected because they most likely represent the principal constituents
that give rise to prominent Raman spectral features seen in spinal tissue.
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Fig. 2 Schematic of the custom-built Raman spectroscope used in this study. Red lines represent excitation light,
while green lines represent emissions. The zoomed-in area shows the normal incidence of the excitation light to the
transverse plane of the tissue slice. Note that the laser spot position was not fixed amongst tests, although the spot
was always constrained to the white matter.

	
  
Certain chemicals were chosen for their unique spectral characteristics, while others
were chosen as general representations of their class of biomolecule. For example,
triolein, a symmetrical triglyceride, was chosen as a representation of typical lipid
vibrational modes, such as CH2 twisting and bending. All constituents, with the
exception of triolein, which was purchased in solution, were purchased and analyzed as
lyophilized powders. Powders were placed in a cylindrical quartz cuvette, and triolein
was placed in a custom borosilicate glass tube with stopper. Each spectrum was
collected as 1,200 accumulations of 1.0-second integrations (total time of 20 minutes),
and a minimum of 3 spectra were collected for each constituent. Spectra from the 11
biochemical species were used for regression analysis.

12

3.7 Spectroscopic data analysis
Spectroscopic data sets were analyzed using MATLAB (Release 2011a; The
Mathworks Inc., Natick, MA). Spectra were cropped to the finger print region of organic
molecules (400 cm-1 to 1800 cm-1) and baseline corrected using the ‘msbackadj’
function in MATLAB. For each spectrum, the ‘msbackadj’ function estimated a baseline
within multiple shifted windows (of 200 cm-1 width) and regressed the baseline using
spline approximation before subtracting it from the spectrum. In this way, all Raman
features narrower than 200 cm-1 are preserved, while those wider are considered a
product of background fluorescence and therefore removed. Because the tissue slices
were sufficiently thin, emissions from the underlying PTFE membrane were collected
coincidently with tissue emissions, causing PTFE spectral features to appear within the
tissue spectra. To correct for unwanted PTFE spectral features, an averaged PTFE
membrane spectrum was subtracted from all tissue spectra. Subtraction was not
performed on biochemical constituent spectra. Spectra were then smoothed using the
‘mssgolay’ function in MATLAB, which applied a Savitzky-Golay smoothing filter.
Standardization was performed by mean centering the data and dividing by the
standard deviation, i.e. standard normal variable (SNV) transformation. For qualitative
assessment, a numerical value was assigned to 10 peaks of interest present within the
tissue spectra using the ‘findpeaks’ function in MATLAB.
3.8 Modeling of spectroscopic data
A semi-quantitative linear model of the spinal tissue spectra was rendered using partial
least squares (PLS) regression. The PLS regression was performed in MATLAB
(Release 2011a; The Mathworks Inc., Natick, MA) using a modified version of the
13

‘plsregress’ function. PLS regression was chosen for its ability to handle multicollinearity
amongst predictor variables. The Raman spectra of biochemicals of a similar nature
often share characteristic peaks, giving rise to a degree of correlation and hence
necessitating the need for a regression technique capable of managing
multicollinearity.26 Such was the case for the biochemical constituents chosen for this
model (See Raman spectroscopy of biochemical constituents). The goal of the PLS
regression model was to describe the commonality between the spectra of spinal tissue
and the spectra of the 11 reference biochemical constituents. To this end, we extracted,
from the regression, the relative contribution of each biochemical constituent spectrum
to each spinal tissue spectrum. Then, using the relative contributions, we tracked
fluctuations in each biochemical over the course of the in vitro SCI and cABC treatment
timeframe. The basic form of the PLS regression model is given by:
! = !" + !

(1)

Where Y is an n-by-m response matrix, X is an n-by-p predictor matrix, β is a p-by-m
matrix of linear coefficients, and R is an n-by-m matrix of response residuals. For this
study, Y corresponds to an n-by-m matrix composed of the tissue spectra for a
particular group (e.g SCI at 1 DPI), where n is the number of spectral intensity
observations and m is the number of spectra; X corresponds to an n-by-p matrix
composed of the mean constituent spectra, where p is the number of constituents; and
β corresponds to a p-by-m matrix composed of the relative contributions of each
constituent. PLS regression is a multivariate technique that operates by projecting
predictor and response variables (i.e. X and Y) to a new space. X and Y are

14

simultaneously decomposed to find eigenvectors that explain a maximum amount of the
covariance between X and Y. The projections of X and Y are given by:
! = !! !!! + !!

(2)

! = !! !!! + !!

(3)

Where XS and YS are n-by-ncomp score matrices, with ncomp equal to the number of
allowed PLS components. For this study, ncomp is equal to the total number of
constituents so that ncomp equals p. The columns of XS and YS are the eigenvectors. X
and Y are regressed onto Xs to find the predictor and response loading matrices, XL
and YL respectively. XL is a p-by-ncomp matrix of predictor loadings, with row values
corresponding to coefficients that estimate the original predictor variables; and YL is an
m-by-ncomp matrix of response loadings, with row values corresponding to coefficients
that estimate the original response variables. XR and YR are matrices that contain the
residual from each projection. The linear coefficient matrix, β, can be given in terms of
the response and predictor loading matrices as follows:
! = !!! (!!! )!!

(4)

β provides linear coefficients that represent the relative contribution of each predictor
variable, or constituent, on the response matrix. However, PLS regression may yield
negative coefficients in β, which as contributions have no physical meaning. To
eliminate negative values, the ‘plsregress’ function in MATLAB was modified to enforce
a non-negativity constraint by replacing its original decomposition method of singular
value decomposition (SVD) with non-nonnegative matrix factorization (NNMF). NNMF
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was accomplished using the built-in ‘nnmf’ function. Rows in β were averaged to
produce a mean linear coefficient for each constituent. Please recall that prior to
regression, all spectra were SNV transformed to a mean of 0 and a standard deviation
of 1; this produced standardized coefficients. For simplicity’s sake, the 7 constituents
with the largest standardized linear coefficients, and thus the largest relative
contribution to the tissue spectra, were selected for further analysis and discussion; they
are triolein, actin, cholesterol, collagen type IV, CS-C, histone, and DNA. To assess the
progression of SCI and its treatment with cABC, relative contributions were found using
PLS regression for SCI groups (n=18) and CTL groups (n=9) at 1, 4, and 8 DPI; and for
SCI+cABC groups (n=18) and SCI+Sham groups (n=9) at 4 and 8 DPI. The variable ‘n’
refers to the number of measured spectra.
3.9 Statistical analysis
Statistical analysis was performed using MATLAB (Release 2011a; The Mathworks Inc.,
Natick, MA). Data are given as mean ± standard deviation (SD). All data, excluding that
of SCI+cABC and SCI+Sham groups, were analyzed using one-way or two-way ANOVA
as appropriate, followed by a post-hoc Tukey’s HSD test. Comparison between
SCI+cABC and SCI+Sham groups was conducted using an unpaired Student’s t-test.
For all tests, significance was assessed at p<0.05.
4

RESULTS

4.1 Viability of organotypic cultures
Organotypic spinal cord slices were successfully cultured for up to 14 DIV using the
interface method. Gross tissue morphology was visually inspected under microscopic
16

assistance once per day while in culture. We observed no discernable changes in the
cross-sectional shape of the spinal cord over 14 DIV. Grey matter and white matter
were easily distinguishable by visual examination, and both maintained their original
shape and coloration. No degeneration or migration of the spinal horns or columns was
seen. In most slices, a time-dependent flattening was observed, wherein tissue
migrated outward from its original position, decreasing the height of the slice. Cell death
significantly decreased following 1 DPI (p<0.05, Tukey’s HSD test) [Fig. 3(a)], which
may indicate in vitro healing of the spinal tissue in response to excision and sectioning.
There was no statistically significant difference between groups at 4, 7, 10, and 14 DIV,
suggesting stability of cell death from 4 DIV to 14 DIV. The cell death averages for the
aforementioned groups remained below a value of 12%. To ensure all cultures were
stabilized prior to experimentation, a period of 6 DIV was allowed before the induction of
SCI, as previously seen.27
4.2 Cell death in response to SCI
To induce SCI, a stainless steel weight was dropped from a fixed height onto the center
of the spinal cord slice. Gross tissue morphology was visually inspected at 1, 4, and 8
DPI. Starting at 4 DPI, we observed a slight curling of the slice edges away from the
culture insert membrane, which indicates a loss of cell or extracellular matrix adhesion
at the periphery. However, no changes in structure, location, or coloration of the white
and grey matter were observed. A PI fluorescence assay was used to assess cell death
at 1, 4, and 8 DPI. Compared to their controls, injured slices at each DPI time point
demonstrated significantly increased cell death (p<0.05, Tukey’s HSD test): 1 DPI
(12.3±4.1 vs. 7.9±1.9%), 4 DPI (26.7±5.9 vs. 7.7±2.1%), and 8 DPI (35.2±7.5 vs.
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Fig. 3 (a) Bar chart showing the percentage of cell death for uninjured spinal tissue cultures at varying DIV. Cell
death decreases after 1 DIV and remains static at least until 14 DIV. Percentage of cell death was determined as
described in Materials and Methods, and data are expressed as mean + SD. Statistical significance was determined
using one-way ANOVA followed by a post-hoc Tukey’s HSD test. Significance was assessed at p<0.05 and is
denoted by an asterisk *. (b) Percentage of cell death for SCI groups at varying DPI. CTL groups are uninjured. All
SCI groups show a significant increase in cell death relative to controls. Statistical significance was determined using
two-way ANOVA followed by a post-hoc Tukey’s HSD test and was assessed at p<0.05. An asterisk denotes
significance between SCI and CTL groups, while # denotes significance between SCI groups only. (c) Representative
micrographs (10X) of PI staining. Scale bar=200 µm and is applicable to all micrographs. Noticeable increases in
florescence are demonstrated for all groups.

	
  
10.9±4.5%) [Fig. 3(b)]. Additionally, injured slices demonstrated a monotonic increase in
cell death over time (p<0.05, Tukey’s HSD test) (12.3±4.1% @1 DPI, 26.7±5.9% @4
DPI, 35.2±7.5% @8 DPI). Two-way ANOVA suggests there is a synergistic effect of
time and injury on the severity of cell death (interaction p-value=5.18E-09).
4.3 Raman Assignments
Raman spectra of spinal cord slice cultures were collected as previously described.
Prominent Raman bands were labeled with a peak wavenumber value and assigned to
a vibrational group/mode (Table 1). Vibrational groups were then assigned to a probable
biochemical based on biological relevance to spinal tissue.
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Table 1 Band assignments for spinal tissue spectra. Greek letters denote the type of vibrational mode (υ=stretching,
υs=symmetric stretching, δ=bending) and qualifiers denote the specific type of stretch/bend. Reference numbers refer
to the assignment’s source.
Peak Wavenumber
-1
(cm )

Vibrational Group/Mode

Biochemical Assignment

Reference
Number

540

C-OH

Saccharides

28

643

δ(C-C) twisting, C-S

Tyrosine

29, 30, 31

700

Sterol ring

Cholesterol

17, 32

890

C(1)-H

β-anomers

28, 33, 34

913

C-OH

Saccharides

28, 35

1003

υs(C-C) breathing

Phenyalanine

30, 33

1064

υ(C-C) stretching

Lipids

28, 31, 33

1137

C-H, C-OH

Saccharides

16

1300

δ(CH2) twisting

Lipids

31, 32, 35

1445

δ(CH2) bending/scissoring

Lipids

30-32

1660

Amide I / υ(C=O) stretching

Proteins / lipids

30-32

4.4 Culturing has a negligible effect on the Raman spectra of organotypic spinal tissue
To study the effect culturing has on the Raman features of spinal tissue, spectra were
collected for cultured slices at 7, 10, and 14 DIV. As a control, spectra were collected
from uncultured slices immediately following the excision and slicing procedure. Figure
4A shows the mean, baseline-corrected, SNV transformed spectrum for each of the
aforementioned groups. Spectra are stacked so that each spectrum is completely and
easily discernable. In order to clearly see the variation between cultured and uncultured
slices throughout the culture timeline, we provide difference spectra using the
uncultured slice group as a reference [Fig. 4(b)]. Between-group comparison of peak
intensity shows a statistically significant decrease at 700 cm-1 (sterol ring of cholesterol)
between 7DIV/ 10 DIV and uncultured slices (p<0.05, Tukey’s HSD test) (Table 2).
There are no statistical differences at any remaining peaks. These results indicate a
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Fig. 4 (a) The mean, baseline-corrected, SNV-transformed spectra of uninjured, cultured spinal tissue at 6, 10, and
14 DIV. An uncultured spinal tissue spectrum is presented for comparison. Spectra are stacked to clearly show
features. (b) Difference spectra obtained using the uncultured spectrum as a reference. The goal was to visualize the
effect time in culture has on tissue spectra. Note that difference spectra were generated before stacking, using zerocentered spectra.

Table 2 Statistical comparison between peak intensities of uninjured groups at varying DIV, as determined by oneway ANOVA followed by a post-hoc Tukey’s HSD test. Significant was assessed at p<0.05. Groups with dissimilar
letters are significantly different. Dashes (-) denote no statistical significance between any groups.
Uninjured Groups

	
  

Peak Wavenumber
-1
(cm )

p-value

540

0.3243

-

-

-

-

700

0.0078

A

B

B

A,B

890

0.1213

-

-

-

-

913

0.0765

-

-

-

-

1003

0.0796

-

-

-

-

1064

0.4445

-

-

-

-

1137

0.1786

-

-

-

-

1300

0.0519

-

-

-

-

1445

0.4305

-

-

-

-

1660

0.3895

-

-

-

-

Uncultured
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6 DIV

10 DIV

14 DIV

possible drop in cholesterol concentration following initial incubation. Between 7 and 14
DIV, however, we can infer there are no significant changes in the biochemistry
contributing to Raman spectral features. These data, in conjunction with data on cell
death, suggest a period of quiescence during the tissue’s second week in culture.
4.5 Effect of SCI on the Raman spectra of organotypic spinal tissue
To assess Raman spectral changes in response to SCI, spectra were collected for SCI
groups at 1, 4, and 8 DPI. Spectra for uninjured CTL groups were collected at similar
times. Figure 5(a) shows the mean, baseline-corrected, SNV transformed spectrum for
SCI groups at 1,4, and 8 DPI. Statistical comparison between peak intensities was
performed using one-way ANOVA with a post-hoc Tukey’s HSD test (p<0.05) (Table 3).
For simplicity, only peaks of statistical significance are discussed. Note that a relative
change in peak intensity is representative of a relative change in the concentration of a
peak’s assigned biochemical. Monotonic decreases in intensity were seen at 1300 cm-1
[δ(CH2) twisting of lipids] and 1445 cm-1 [δ(CH2) bending/scissoring of lipids]. These
results suggest a time-dependent monotonic decrease in lipid concentration following
SCI. Similar results have been observed using an in vivo model of SCI.16, 17 The peak at
700 cm-1 (sterol ring of cholesterol) decreased between 1 DPI and 4 DPI, and is visually
absent from the spectrum at 8 DIV. Other notable decreases occurred at 1064 cm-1
([υ(C-C) stretching of lipids] and 1660 cm-1 [Amide I of proteins, υ(C=O) stretching of
lipids] between 4 DPI and 8 DPI. Monotonic increases were observed at 540 cm-1 (COH of saccharides) and 913 cm-1 (C-OH of saccharides), with an additional increase at
1137 cm-1 (C-H, C-OH of saccharides) between 4 DPI and 8 DPI. Interestingly, all
increasing peaks are attributed to the deformation of C-OH. To further illustrate the
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Fig. 5 (a) The mean, baseline-corrected, SNV-transformed spectra of untreated, injured spinal tissue at 1, 4, and 8
DPI. Spectra are stacked to clearly show features. (b) Difference spectra obtained using uninjured control groups* (at
their respective DPI) as a reference. The goal was to visualize the progression of injury over time relative to the
uninjured state. Note that difference spectra were generated before stacking, using zero-centered spectra.

	
  

Table 3 Statistical comparison between peak intensities of SCI groups at varying DPI, as determined by one-way
ANOVA followed by a post-hoc Tukey’s HSD test. Significant was assessed at p<0.05. Groups with dissimilar
letters are significantly different.
SCI Groups
Peak Wavenumber
-1
(cm )

p-value

1 DPI

4 DPI

8 DPI

540

3.85E-08

A

B

C

700

2.55E-19

A

B

B

890

2.28E-04

A

A,B

B

913

1.94E-17

A

B

C

1003

1.69E-12

A

A

B

1064

8.29E-07

A

A

B

1137

6.41E-09

A

B

B

1300

9.95E-14

A

B

C

1445

2.06E-21

A

B

C

1660

2.66E-05

A

A

B
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aforementioned spectral changes, difference spectra between SCI groups (1, 4, and 8
DPI) and their corresponding controls (Uninjured slices at 1, 4, and 8 DPI, respectively)
are provided in Figure 5(b). The goal of the difference spectra is to visualize the
progression of injury over time, relative to the uninjured tissue state.
4.6 Effect of cABC treatment on the Raman spectra of injured organotypic spinal tissue
Injured spinal cord slices were treated with cABC (0.2 U/ml) 1-hour post-injury and
spectra were collected at 4 and 8 DPI. Figure 6 shows the mean, baseline-corrected,
SNV transformed spectrum for cABC-treated groups (SCI+cABC) and sham-treated
control groups (SCI+Sham) at 4 and 8 DPI. Statistical comparison between cABC and
Sham-treated groups was performed using an unpaired Student’s t-test, and
significance was assessed at p<0.05 (Table 4). Compared to their control, cABC-treated
slices showed significantly decreased intensity at 540 cm-1 (C-OH of saccharides)
(p=7.61E-05 for 4 DPI; p=3.05E-03 for 8 DPI) and at 1137 cm-1 (C-H, C-OH of
saccharides) (p=1.06E-02 for 4 DPI; p=1.49E-02 for 8 DPI), and significantly increased
intensity at 890 cm-1 [C(1)-H of β-anomers] (p=2.34E-02 for 4 DPI; p=2.39E-07 for 8 DPI)
and at 643 cm-1 [δ(C-C) twisting of proteins] (p=2.56E-04 for 4 DPI; p= 4.43E-02 for 8
DPI). The peak at 643 cm-1 is completely absent from the spectra of sham-treated
slices, which suggests a sudden rise in a new vibrational mode, C-C twisting/C-S
stretching, following cABC treatment. At 8 DPI only, cABC slices showed significantly
increased intensity at 1064 cm-1 [υ(C-C) stretching of lipids] (p=3.83E-04). The intensity
changes at 540 cm-1, 1064 cm-1, and 1137 cm-1 are antagonistic to those produced by
SCI. Again to further illustrate the aforementioned spectral changes, difference spectra
between cABC-treated groups and their sham-treated controls are provided in Figure 6.
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Fig. 6 The mean, background corrected, SNV-transformed spectra of cABC-treated and sham-treated spinal tissue at
(a) 4 DPI and (a) 8 DPI. Spectra are stacked to clearly show features. Note that difference spectra (cABC-Sham) were
generated before stacking using zero-centered spectra.

	
  
Table 4 Statistical comparison between peak intensities of cABC groups and their sham controls at varying DPI, as
determined by an unpaired Student’s t-test. For quick reference, asterisks indicate level of significance, *p<0.05,
**p<0.01.
p-value
Peak Wavenumber
-1
(cm )

cABC vs. Sham
4 DPI

cABC vs. Sham
8 DPI

540

**7.61E-05

**3.05E-03

643

**2.56E-04

*4.43E-02

700

5.11E-01

3.70E-01

890

*2.34E-02

**2.39E-07

913

6.63E-01

2.75E-01

1003

7.88E-01

9.29E-01

1064

8.41E-02

**3.82E-04

1137

*1.06E-02

*1.49E-02

1300

8.86E-01

6.60E-01

1445

5.37E-02

7.51E-01

1660

3.42E-01

2.52E-01
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4.7 Success of PLS regression model
Table 5 shows the percentage of variance explained in Y (matrix of response variables,
see Equation 1) by the PLS regression for each modeled group. Explained variance (η2)
serves as an index of goodness of fit and is analogous to the coefficient of
determination (R2), typically used in multiple regression models. Values for η2 range
from 63.66 to 84.68%. We can see from the response residual, taken as the difference
between the fitted response and the average measured tissue spectrum, that a large
portion of unexplained variance comes from the 540 cm-1 band and 1064 cm-1 band (Fig.
7). This is especially true of SCI groups assessed later in culture, e.g. 8 DPI, as these
bands increase significantly over the course of injury. However, despite the presence of
weaker intensity bands in the fitted response, the PLS regression model is capable of
largely resolving the response variance. Figure 8 shows the mean, baseline-corrected,
SNV transformed spectrum for each of the 7 constituents chosen for discussion. These
spectra were chosen for their higher standardized linear coefficient values, and offer the
largest contribution amongst predictor variables to the PLS fitted response.
4.8 Biochemical variations in response to SCI and cABC treatment
PLS regression was used to ascertain the relative contribution of spectra from 11
predetermined biochemical constituents to the spectra of cultured spinal tissue. As
previously mentioned, the regression model output standardized linear coefficients for
each constituent, which, for the purposes of discussion, will be referred to as a
constituent’s relative contribution. Two models were constructed: the first for SCI groups
and their uninjured controls, and the second for SCI+cABC groups and their
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Table 5. Percent variance explained by PLS regression for each modeled group
Group

Variance explained by model (%)

Uninjured CTL (1 DPI)

83.39

SCI (1 DPI)

84.68

SCI (4 DPI)

75.53

SCI +cABC (4 DPI)

80.48

SCI +Sham (4 DPI)

77.35

SCI (8 DPI)

63.66

SCI +cABC (8 DPI)

71.87

SCI +Sham (8 DPI)

69.61

	
  

	
  
Fig. 7 Measured spinal tissue spectra versus the fitted responses generated by PLS regression. For simplicity control
groups are not shown. Residual is the difference between measured and fitted.
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Fig. 8 The mean, baseline-corrected, SNV-transformed spectra of the 7 biochemical species used for regression
modeling. Spectra are stacked to clearly show features.

	
  
sham-treated controls. Figure 9 depicts the relative contribution of the 7 constituents
(chosen for discussion) for SCI groups at 1, 4, and 8 DPI. For simplification, a single
CTL group was chosen for comparison. Since we observed no significant spectral
differences between CTL groups at 1, 4, and 8 DPI (results not shown), the CTL group
at 1 DPI was chosen arbitrarily to serve this purpose. Data are shown as mean ± SD,
and between-group comparison was performed using a post-hoc Tukey’s HSD test
(p<0.05). A notable increase in relative contribution was observed for CS-C following 1
DPI; and notable decreases were observed for triolein, histone, and DNA following 1
DPI, and for cholesterol following 4 DPI. Figure 10 depicts the relative contributions for
cABC-treated and sham-treated groups at 4 DPI and 8 DPI. Here sham-treated groups
are controls. Between-group comparison was performed using an unpaired Student’s t-
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test, and significance was assessed at p<0.05. At 4 DPI, a significant increase in
relative contribution, relative to the control, was observed for collagen type IV, while
significant decreases were observed for cholesterol and CS-C. Similarly, at 8 DPI, a
significant increase was observed for collagen type IV, while significant decreases were
observed for cholesterol and CS-C.

Fig. 9 Bar chart displaying the relative spectral contributions of biochemical species to injured spinal tissue at 1,4, and 8
DPI. A single uninjured CTL group was chosen for comparison. Note that relative contribution values are unitless, as
they are synonymous to standardized regression coefficients. Data are expressed as mean + SD. Statistical significance
was determined using one-way ANOVA followed by a post-hoc Tukey’s HSD test. Significance was assessed at p<0.05
and groups with dissimilar letters are significantly different.
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Fig. 10 Bar chart displaying the relative spectral contributions of biochemical species to cABC-treated and shamtreated spinal tissue at (a) 4 DPI and (b) 8 DPI. Note that relative contribution values are unitless, as they are
synonymous to standardized regression coefficients. Data are expressed as mean + SD. Statistical significance was
determined using an unpaired Student’s t-test. Asterisks indicate levels of significance, * p<0.05, ** p<0.01.
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DISCUSSION

Raman spectroscopy is a powerful tool in examining compositional and conformational
phenomena in living tissue. As mentioned, its success is demonstrated in the qualitative
assessment of spinal cord tissue. However, no reports to date have used Raman
spectroscopy to examine the effects of enzymatic treatment on SCI. This study presents
a novel spectroscopic investigation, in qualitative and semi-quantitative nature, of SCI
and its treatment with cABC in an organotypic model.
Firstly, we generated a spectroscopic characterization of organotypic SCI using
Raman spectroscopy. This allowed us to observe, from a spectroscopic perspective,
which pathobiological events of SCI, if any, were functional in an organotypic setting.
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We demonstrate that data in the present study exhibit strong agreement with previously
established models of in vivo SCI16, 17; however, there are several developments that
warrant discussion. Please note that the following discussion refers to significant
differences between SCI groups and uninjured control groups, and that references for
Raman assignments are listed in Table 1.
Relative to uninjured tissue, we observed a monotonic decrease in peak intensity
for bands at 1445 cm-1 and 1300 cm-1, over the timeframe of SCI. Both bands are
attributed to CH2 bending in lipids, so accordingly their decrease in intensity likely
correlates to a decrease in lipid concentration. This is because, under constant test
conditions, spectral intensity (at a particular frequency) is assumed proportional to the
concentration of whichever Raman-active chemical is vibrating at that frequency.16
Since all tissue samples were maintained in vitro, a reduction in concentration implies
either a degradation of the chemical, or its secretion from the tissue matrix. Reduction in
lipid concentration is concurrent with demyelination, a hallmark feature of the glial scar,
wherein axons are stripped of their myelin coating.8,9 Since myelin is largely composed
of lipid molecules, a mass removal would likely reduce CH2 vibrational modes, and thus
decrease correlated band intensities.
Monotonic increases in peak intensity were observed at 540 cm-1 and 913 cm-1,
both of which are attributed to C-OH deformation. For either band, the C-OH group is
assigned to saccharides. Applicably, the 540 cm-1 band was observed in the spectra of
aggrecan, a type of CSPG, and more specifically in the spectra of chondroitin sulfate-A
and chondroitin sulfate-C, the unbranched polysaccharide side-chains of CSPGs.36 This
report36 demonstrates an increase in intensity at 540 cm-1 during CSPG aggregation, a
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well-documented event of the glial scar1,11-14,16, suggesting that our observation may be
more specifically, and perhaps more appropriately, assigned to CSPGs. This additional
assignment stands to reason, if only because CSPGs are a major Raman-active
component of injured spinal tissue’s extracellular matrix16, and would therefore produce
a significant spectral contribution. It should be noted that Raman spectroscopy is
typically incapable of detecting chemicals of a concentration less than one part per
thousand; so presumably, only chemicals of relatively high concentration within spinal
tissue can produce observable spectral phenomena. If the assignment were
hypothesized correctly, the increase at 540 cm-1 would correlate to an upregulation of
CSPGs, which is in agreement with SCI characteristics. The 913 cm-1 band has been
observed in monosaccharides, such as glucose and ribose35; however, intriguingly is
not found in the spectra of chondroitin sulfate, a chain of alternating monosaccharides
that contains glucuronic acid, which is structurally similar to glucose. Nevertheless, the
increase at 913 cm-1 suggests an increase in saccharide concentration following injury,
which may also correlate to the upregulation of CSPGs.
In all observed tissue spectra, the peak at 913 cm-1 overlaps with neighboring
bands occupying the region from 800 cm-1 to 970 cm-1. Bands in this region are largely
attributed to C-O-C deformation seen in the glycosidic linkages of oligo- and
polysaccharides.37 We observed a monotonic increase in intensity over this entire
region, which suggests the presence of newly formed glycosidic linkages. This is
concurrent with CS-GAG polymerization during CSPG upregulation.
Overall, these spectral phenomena are grossly concurrent with in vivo SCI, in
that they suggest demyelination and CSPG upregulation, two major hallmarks of the
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glial scar. Prior models of in vivo SCI demonstrate similar occurrences at 1445, 1300,
and 700 cm-1 16,17; in the regions of 850-1000 cm-1 16,17; and below 600 cm-1 16. This last
occurrence was not unanimous, but perhaps only because wavenumbers below 600
cm-1 were left unobserved. Histological staining for myelin and immunohistochemical
staining for chondroitin sulfate (types A and C) were used as references for spectral
observations in the former study.16 Said staining revealed a decrease in myelin levels as
early as 4 DPI, and an increase in chondroitin sulfate levels, also as early as 4 DPI.
These results, while not conclusive in their correlation to spectral observations, serve as
positive evidence for their spectral hypotheses, and by extension our spectral
hypotheses, regarding CSPG and myelin variations.
Secondly and subsequent to in vitro SCI, spinal tissue cultures were treated with
cABC, a bacterial enzyme shown to attenuate the inhibitory properties of the glial scar.
We demonstrate several key differences between the Raman spectra of cABC-treated
spinal tissue and their sham-treated controls. This is significant for two reasons. First, it
demonstrates that enzymatic treatment of SCI may be assessed spectroscopically.
Second, it allows us to use the spectral differences to elucidate previously unknown
mechanisms involved in the enzymatic reaction of cABC on injured spinal tissue. Unless
stated otherwise, the following differences were observed between cABC-treated
groups and sham-treated control groups at both collection times (4 and 8 DPI), and are
statistically significant.
The most notable difference, relative to the sham control, was a decrease in
peak intensity at 540 cm-1. This change is antagonistic to the injury response and,
based on our previous assignment for this band, would suggest a decrease in CSPG
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concentration. Reduced CSPG concentration is in agreement with the characterized
action of cABC since the enzyme degrades the CS-GAG chains of CSPG1, rendering its
original chemical structure forfeit. Furthermore, this result fine-tunes the 540 cm-1
chemical assignment from CSPG as a whole to, more specifically, its CS-GAG chains.
This is because cABC only interacts with the saccharide chains of CSPGs and not the
protein core38, so any spectral variations produced by cABC are firstly assumed a result
of the enzyme-substrate interaction.
We observed another notable decrease in peak intensity at 1137 cm-1. This band
is attributed to C-H and C-OH deformation, and assigned to saccharides, suggesting a
reduction in saccharide concentration post-treatment. If correctly assigned, this
indicates depolymerized saccharides are eliminated from the extracellular matrix
following the cABC enzymatic reaction. However, we cannot postulate a more direct
correlation between the 1137 cm-1 band and cABC treatment, as the band has not been
strongly observed in the spectrum of cABC or its substrate, chondroitin sulfate (see
Figure 8 for CS-C spectrum).
We observed an increase in peak intensity at 890 cm-1, which bears a specific
assignment to β-anomers. β-anomers are cyclic saccharides that have a trans
configuration between the OH group on C(1), also referred to as the anomeric carbon,
and the CH2OH2 group on C(5). The exact vibrational group(s) that give rise to this band
are debated; although the band appears to be resultant of a combination of vibrations
found in β-anomers, including CH2, C-O(5), and C(1)-H deformations.35 Several studies
affirm C(1)-H deformation as the primary contributor.28, 33, 34 Interestingly, CS-GAG
chains are composed entirely of β-anomers, specifically glucuronic acid and
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galactosamine. These two monosaccharides are repeatedly linked together by
glycosidic linkages between the C(1) of one monosaccharide and the C(4) of another to
form chondroitin sulfate. Raman spectral analysis of chondroitin sulfate reveals a strong
appearance of the band in the spectra of chondroitin-6-sulfate (CS-C) and a medium
appearance in that of chondroitin-4-sulfate (CS-A).36 This data, along with details
regarding the high extracellular concentrations of CSPGs during SCI39, suggests that
our observation in spinal tissue may be more specifically assigned to chondroitin sulfate.
Yet, while this information helps elucidate the source of spectral activity, it does not
convey the reason for an increase in intensity. Any correlation between cABC treatment
and increased β-anomer deformation is not apparent in the literature. However, we can
speculate a cause. Studies have shown that cABC enzymatically degrades CS-GAG
chains by cleaving the glycosidic linkages between its saccharide subunits40, which
would directly affect the behavior of C(1), as it is an integral part of the linkage. Thus,
cleavage of the linkage may increase deformation in C(1)-H, perhaps by alleviating
vibrational hindrances caused by surrounding functional groups of the CS-GAG chain.
A distinctive band at 643 cm-1 was observed in the spectra of cABC-treated
tissue, but not in sham-treated controls. Vibrations at 643 cm-1 have two common
assignments in the literature: the C-C twisting mode in tyrosine29,31, specifically within
the phenol side-group, and the C-S stretching mode in sulfotyrosine.30 Because of the
ambiguity in assignment for this band, we offer two possible explanations for its
occurrence. First, if we assume the band is correctly assigned to C-S stretching in
sulfotyrosine, its occurrence is likely an outcome of protein tyrosine sulfation, a posttranslational modification that is carried out on a variety of secreted and intra-membrane
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proteins.41 Protein tyrosine sulfation largely serves to strengthen, and thereby control,
the interaction between secreted proteins and pathogens during the innate immune
response.41 Treatment by the bacterial-derived cABC has been known to invoke an
immune response10, and even in the extrinsically restricted environment of organotypic
culture, spinal tissue is capable of producing an innate immune response without the
influences of systemic cells because of the presence of microglia.42 If so, tyrosine
sulfation would expectedly be a component of that response. Second, if the band is
instead assigned to C-C stretching in tyrosine, its occurrence is likely due to
conformational/compositional changes in protein structure. The spectral activity of the
phenol side-group is highly sensitive to the orientation of its tyrosine residue29, so by
affecting tyrosine orientation, it is feasible for a conformational/compositional change to
increase intensity. This hypothesis is supplemented by a negative frequency shift from
643 cm-1 to 640 cm-1, occurring between 4 and 8 DPI. The shift signifies a change in the
stress/strain state of protein tyrosine, most likely caused by new vibrational groups
surrounding protein tyrosine. Moreover, the shift signifies a continual
conformational/compositional change to protein structure, one that evolves over the
course of treatment. It is unclear exactly which proteins underwent changes, but we
maintain CSPG core proteins as plausible candidates.
Lastly, we observed an increase in peak intensity at 1064 cm-1 following 8 DPI.
This band is attributed to C-C stretching in lipids. An increase in lipid concentration posttreatment, however subtle, may indicate remyelination facilitated by the action of cABC,
whether it be on previously demyelinated or newly sprouted axons. Under normal SCI
conditions, CSPGs inhibit remyelination by physically and chemically restricting
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endogenous oligodendrocyte progenitor cells (OPCs) from differentiating and
consequently attaching to bare axons.8 During treatment, however, cABC overrides this
inhibitory response on remyelination by enzymatically degrading CSPGs. With reduced
CSPG action, OPCs are now free to myelinate. Intriguingly, this is the only significant
difference that was not observed at both DPI. The lack of statistical difference between
cABC-treated and sham-treated peaks at 1064 cm-1, and furthermore at 1300 cm-1 and
1445 cm-1 (all assigned to lipids), following 4 DPI, suggests that cABC-treated tissue did,
in fact, undergo demyelination. Therefore any subsequent increase in lipid
concentration may correlate to remyelination.
While comparing spectral intensities elucidates us to changes in concentration
for biochemical species, it does so qualitatively and somewhat presumably, as it relies
on tentative biochemical assignments. To help quantify the changes in biochemical
species inherent in spinal tissue, we constructed two semi-quantitative linear models
using PLS regression: one for SCI groups at varying DPI (1, 4, and 8 DPI), with
uninjured controls, and another for cABC-treated groups at varying DPI (4 and 8 DPI),
with sham-treated controls. For each biochemical constituent (chosen as a predictor
variable), the PLS regression provides a standardized linear coefficient value that
represents the constituent’s relative contribution to the spinal tissue spectrum (chosen
as the response variable). Note that the following discussion refers to significant
between-group changes in relative contribution. A change in contribution indicates that
more/less of a biochemical is observed in the spectra of spinal tissue, which implies a
change in the biochemical’s concentration.
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From our regression model of SCI, we demonstrate that triolein and cholesterol
monotonically decrease following injury. As previously stated, certain constituents were
chosen for their unique spectral characteristics, while others were chosen as general
representations of their class of biomolecule. Triolein and cholesterol were chosen as
representation for typical lipid vibrational modes, such as CH2 twisting and bending,
often present in the region from 1300 cm-1 to 1470 cm-1. A decrease in lipid contribution
is concurrent with our spectral observations, and is indicative of demyelination. Histone
and DNA were chosen as another such representation, albeit slightly different in nature.
These constituents represent the characteristic vibrational modes contained within cell
nuclei. We demonstrate a decrease in histone and DNA between 1 DPI and 4 DPI, with
no further changes following 4 DPI. The results for histone are in agreement with other
reports43,44, which demonstrate a release of histones from apoptotic cells during injury.
From our results, we might further assume that histones are released from the
extracellular matrix as well. Interestingly, the results for DNA are in disagreement with
other reports that have spectroscopically characterized various pathologies.45, 46 When
DNA undergoes denaturation - a regular occurrence in apoptotic cells and one well
characterized in CNS injury18 - its secondary structure changes, which has a significant
affect on its absorptivity.47, 48 Reports demonstrate that the absorptivity change
associated with DNA denaturation produces Raman hyperchromic effects47, 48, so one
would assume the contribution of DNA to increase, rather than decrease, in response to
injury. However, these findings may prove irrelevant, as they were conducted with an
excitation source ranging below 300 nm (compared to ours of 785 nm). We maintain
that the Raman hyperchromic effect may not be detectable for larger wavelengths; or
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rather may not be detectable amongst the assortment of spectral activity in spinal tissue.
CS-C differed most notably out of the seven constituents, increasing by the largest
factor between 1 and 8 DPI. An increase in chondroitin sulfate concentration during the
first week of injury is well documented39, and our results are in agreement.
From our regression model of cABC-treated SCI, we demonstrate a higher
contribution from collagen type IV relative to sham-treated controls. Collagen type IV
has not been previously characterized during cABC-treatment of SCI, so it is difficult to
draw firm conclusions as to the cause of this result. However, one study reports that
fibroblast-like cells present in the matrix of the annulus fibrosus, a component of the
intervertebral disc, upregulate collagen in response to cABC treatment in an attempt to
replenish the extracellular matrix of the disc.49 They observed a significant increase in
collagen concentration as early as 7 days after cABC treatment. While the study is
merely analogous to spinal tissue treatment, it is certainly helpful in elucidating a
supposition. From their work, we adopt the hypothesis that collagen synthesis in spinal
tissue is activated by chemical or mechanical changes to the extracellular matrix
following CSPG degradation. Studies demonstrate that collagen has its own axonal
inhibitory properties, and that the collagen-rich basal membrane found in spinal tissue
acts as a barrier to axonal regrowth.6,9 So it is possible that cells upregulate collagen in
an effort to restore or compensate for the inhibitory potential lost during cABC-treatment.
This hypothesis implies that fibroblasts or fibroblast-like cells capable of synthesizing
collagen, such as astrocytes, are present in the spinal tissue cultures. We demonstrate
a lower contribution from cholesterol, relative to sham-controls, and no significant
differences in triolein contribution. These data conflict with our initial spectra-derived
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hypothesis of a decrease in lipid concentration following 8 DPI. This suggests one of
two things. Either the 1064 cm-1 band, which is the band that prompted the initial
hypothesis, is incorrectly assigned to lipids or perhaps shares a latent assignment to
another, more relevant molecule; or the model’s explanation of variance within this
spectral region is sufficiently low as to cause discrepancy between results. If the model
were incapable of properly explaining variance in intensity at 1064 cm-1, then any
changes in intensity, below a certain threshold, would be lost. A large residual around
the 1064 cm-1 band, relative to all other bands (see Fig. 7), lends credibility to the latter
supposition. Lastly, we demonstrate a sizeable decrease in CS-C relative to shamtreated controls. At 8 DPI, CS-C contribution between cABC and sham-treated groups
differs by the largest factor amongst constituents. A decrease in CS-C is in agreement
with our spectral observations, as well as previous works1, 11-14, which demonstrate
reduction in CS-GAGs concentration as early as 24 hours post-treatment.
6

CONCLUSION

In conclusion, we demonstrate that Raman spectral variations characteristic of SCI can
be observed using an organotypic model. These variations are hypothesized to
correlate with demyelination, CSPG upregulation, and apoptosis, among other events
within injured spinal tissue. This is significant in that it indicates prominent
pathobiological events associated with in vivo SCI can be recapitulated in vitro, as far as
spectral analysis is concerned, so that we have a functioning model of SCI. Moreover,
we have a model of SCI that can be systematically treated and assessed within a
controlled environment. To that effect, we demonstrate for the first time that Raman
spectral variations are discernable during cABC treatment of SCI. Observed variations
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are hypothesized to correlate with the enzymatic degradation of CS-GAGs, protein
conformational/ compositional changes, and remyelination. PLS regression modeling
confirms changes in lipid (presumably that of myelin) and CSPG concentration during
SCI and its cABC treatment, and provides a semi-quantitative measure of these
changes. Overall, these data establish Raman spectroscopy as a viable resource for
monitoring the treatment of SCI with the enzyme, cABC. As a result, it is intriguing to
consider the implications of Raman spectroscopy in up-and-coming chondroitinasebased SCI therapies.
7

FUTURE WORK

The PLS regression produced an average explained variance of 75.82%, leaving
marked room for improvement. We conceive three primary reasons for the unexplained
variance. First, the PLS model operates on the assumption that the Raman spectra of a
biochemical in isolation is identical to its Raman spectra once its been incorporated in
tissue. If this assumption is broken, and the incorporation of a biochemical causes shifts
in frequency, the model’s ability to predict standardized coefficients could be adversely
affected. Second, the set of predictor variables, i.e. biochemical constituents, chosen for
this model may not have been optimal. If Raman bands found in the tissue are missing
from the collection of reference spectra, the model will have a tendency to overfit certain
predictor variables. This may have been the case for the 1064 cm-1 band. To correct
this issue, one might consider using a semi-parametric model that accounts for the
omission of relevant predictor variables using a non-parametric term. However, a
challenge presents itself in creating a semi-parametric model with non-negative
restrictions. Third, the non-negativity constraint on the regression may have increased
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unexplained variance, relative to unconstrained regression. Non-negative matrix
factorization is not an exact factorization, but rather an approximation with a residual
error component. Forcing non-negativity on the decomposition of predictor and
response variables is necessary for analysis, but produces less than ideal results by
introducing this error.
Other improvements are needed in the analysis of spectroscopic data. Our
analysis thus far has relied on the tentative assignment of Raman bands to
biochemicals based on work from independent studies. While this practice is not an
unusual tactic, it is highly presumptive and only aids in drawing hypothesis regarding
spectral occurrences, rather than solid conclusions. To better affirm these assignments,
it is necessary to isolate and observe the chemical components of relevant
pathobiological events. For example, one might assess the action of cABC on a solution
of isolated CS or CSPG molecules. In situ spectral occurrences could then be
compared to those of the cABC-CS/CSPG solution, so as to elucidate which
occurrences were a direct result of the enzyme-substrate interaction and which were
auxiliary. Additionally, a similar comparison could be performed using the spectra of
activated glial cells in isolation of an extracellular matrix. This would help elucidate
which spectral occurrences correlate specifically to cells versus the extracellular matrix,
further identifying their source.
One major disadvantage of the organotypic model is its lack of long-term viability.
Reports show organotypic cultures of spinal cord tissue only maintain viability for an
average of 2 weeks.20,22,50,51 Thus, to assess treatment over the full timeframe of SCI,
the next major step for this work is in vivo experimentation. Ideally, injury and treatment
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will be performed in a surgical setting, and the animal will be allowed a subsequent
period of recovery. Herein lie two divergent paths that may be taken. Spectroscopic
analysis will be performed either on excised sections of tissue, which requires
euthanasia, or on the living animal as a whole. The latter is ideal, in that it mimics
clinical applications, but it presents a wide-range of challenges, including imaging
through bone and connective tissue, imaging in a vascularized environment, and
anesthetizing the animal during imaging, to name a few. However, despite these
challenges it is intriguing to consider RS for the clinical assessment of cABC SCI
treatment. Furthermore, the generation of an in vivo model using a mouse would allow a
more precise assessment the organotypic model’s ability to recapitulate major
pathobiological events of SCI. While data in this study largely agreed with data of our
previous in vivo model16, said model was constructed using an entirely different model
organism, the rat. Cross-species comparison is useful in providing insight to the
similarities between the models; however there is little way of inferring which differences
correlate to the species and which to the models.
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